NDFIP2 and hepatocellular carcinoma: Zhou et al. demonstrated that Gly-tRF can reduce NDFIP2 mRNA levels by binding to its 3’UTR, thereby promoting hepatocellular carcinoma cell migration and EMT; conversely, Gly-tRF deletion inhibited these processes [73] (Fig. 2d).